JAMES B CAREY
Real Estate Commission in Downingtown, PA

License number
Pennsylvania RS221190L
Category
Real Estate Commission
Type
Real Estate Salesperson-Standard
Address
Address
Downingtown, PA 19335

Professional information

James Carey Photo 1

Biaryl Substituted Triazoles As Sodium Channel Blockers

US Patent:
2006018, Aug 17, 2006
Filed:
Mar 12, 2004
Appl. No.:
10/549790
Inventors:
Prasun Chakravarty - Edison NJ, US
Michael Fisher - Ringoes NJ, US
Brenda Palucki - Hillsborough NJ, US
Min Park - Whippany NJ, US
William Parsons - Belle Mead NJ, US
Bishan Zhou - Hoboken NJ, US
James Carey - Downingtown PA, US
Douglas Frantz - Downingtown PA, US
Michael Kress - Exton PA, US
Damian Weaver - Lansdale PA, US
International Classification:
C07D 417/02, C07D 403/02, C07D 413/02
US Classification:
544132000, 544405000, 544366000, 546272400, 544333000, 546210000, 548200000, 548131000, 548215000, 548266200
Abstract:
Biaryl substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof, and a process for making such compounds and salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, epilepsy, irritable bowel syndrome, depression, anxiety, multiple sclerosis, and bipolar disorder, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds. A method of administering local anesthesia comprises administering an effective amount of a compound of the instant invention, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier.


James Carey Photo 2

Biaryl Substituted Triazoles As Sodium Channnel Blockers

US Patent:
2005011, Jun 2, 2005
Filed:
Mar 12, 2004
Appl. No.:
10/799230
Inventors:
Prasun Chakravarty - Edison NJ, US
Michael Fisher - Ringoes NJ, US
Jeffrey Fisher - Ringoes NJ, US
Brenda Palucki - Hillsborough NJ, US
Min Park - Whippany NJ, US
William Parsons - Belle Mead NJ, US
Bishan Zhou - Hoboken NJ, US
James Carey - Downingtown PA, US
Douglas Frantz - Downingtown PA, US
Michael Kress - Exton PA, US
Damian Weaver - Lansdale PA, US
International Classification:
C07D413/02, C07D417/02, C07D043/02, A61K031/5377, A61K031/496, A61K031/506
US Classification:
514235500, 514255050, 514253050, 514256000, 514326000, 514365000, 514374000, 514364000, 514341000, 514378000, 544132000, 544333000, 544405000, 544366000, 546210000, 546272400, 548200000, 548215000, 548131000, 548240000, 548266200
Abstract:
Biaryl substituted triazole compounds represented by Formula I, II or III, or pharmaceutically acceptable salts thereof, and a process for making such compounds and salts thereof. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, epilepsy, irritable bowel syndrome, depression, anxiety, multiple sclerosis, and bipolar disorder, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds. A method of administering local anesthesia comprises administering an effective amount of a compound of the instant invention, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier.